NCT00907894View on ClinicalTrials.gov

Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2012

Conditions
Chronic Hepatitis B
Interventions
DRUG

LDT600 (Telbivudine)

LDT600 (Telbivudine)

Trial Locations (7)

Unknown

Novartis Investigative Site, Brussels

Novartis Investigator Site, Frankfurt

Novartis Investigator Site, Starnberg

Novartis Investigator Site, Wuppertal

Novartis Investigator Site, Manila

Novartis Investigator Site, Quezon City

Novartis Investigator Site, Birmingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY